Associations between phosphodiesterase type 5 inhibitors and vascular function: a systematic review and meta-analysis on randomized-controlled trials
Yucong Zhang, Hao Peng, Sheng Xin, Jiaquan Mao, Jun Zhang, Hao Li, Yang Luan, Xiaming Liu, Tao Wang, Jihong Liu, Hanlin Zhang, Wen Song · 2025
Read Associations between phosphodiesterase type 5 inhibitors and vascular function: a systematic review and meta-analysis on randomized-controlled trials by Yucong Zhang, Hao Peng, Sheng Xin, Jiaquan Mao, Jun Zhang, Hao Li, Yang Luan, Xiaming Liu, Tao Wang, Jihong Liu, Hanlin Zhang, Wen Song (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12860173.txt.
Description
Yucong Zhang and co-authors pool randomized trials on whether a class of drugs best known for erectile dysfunction also improves blood vessel health. These drugs may protect the heart, but their effects on vessel measures tied to early disease were uncertain. The team gathered dozens of trials with thousands of subjects.
Compared with placebo, the drugs lowered systolic and diastolic blood pressure, thinned a neck artery wall measure, and slowed pulse wave speed, a sign of stiffness. Blood flow responses and counts of vessel-repair cells rose. A few measures showed no clear change. Checks supported the stability of the pooled results. The authors see promise for early cardiovascular disease, pending more work.
Catalog record
| CREATOR | Yucong Zhang, Hao Peng, Sheng Xin, Jiaquan Mao, Jun Zhang, Hao Li, Yang Luan, Xiaming Liu, Tao Wang, Jihong Liu, Hanlin Zhang, Wen Song |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |